Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Tauschmann

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Diabetes Care|October 17, 2024
Eighteen-Month Hybrid Closed-Loop Use in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter TrialJulia Ware, Janet M Allen, Charlotte K Boughton, et al.
BMJ Open|June 6, 2019
Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocolGianluca Musolino, Janet M Allen, Sara Hartnell, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Automated insulin delivery (AID) systems, physical activity and sports in type 1 diabetes mellitus: joint guidelines of the DDG and ÖDG]Othmar Moser, Ulrike Becker, Louisa van den Boom, et al.
BMJ Open|February 13, 2021
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocolJulia Fuchs, Janet M Allen, Charlotte K Boughton, et al.
Lancet (London, England)|October 8, 2018
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialMartin Tauschmann, Hood Thabit, Lia Bally, et al.
Wiener Klinische Wochenschrift|August 28, 2024
[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association]Antonia-Therese Kietaibl, Ingrid Schütz-Fuhrmann, Latife Bozkurt, et al.
BMJ Open|March 15, 2020
Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocolCharlotte Boughton, Janet M Allen, Martin Tauschmann, et al.
Journal of Diabetes Science and Technology|April 4, 2017
Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial SubstudyKatharine D Barnard, Timothy Wysocki, Vanessa Ully, et al.
Diabetes, Obesity & Metabolism|January 26, 2026
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoringJohn S Pemberton, Robert C Andrews, Katharine Barnard-Kelly, et al.
BMJ Open|July 16, 2017
Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocolLia Bally, Hood Thabit, Martin Tauschmann, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Diabetes Care|October 17, 2024
Eighteen-Month Hybrid Closed-Loop Use in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter TrialJulia Ware, Janet M Allen, Charlotte K Boughton, et al.
BMJ Open|June 6, 2019
Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocolGianluca Musolino, Janet M Allen, Sara Hartnell, et al.
Wiener Klinische Wochenschrift|May 20, 2026
[Automated insulin delivery (AID) systems, physical activity and sports in type 1 diabetes mellitus: joint guidelines of the DDG and ÖDG]Othmar Moser, Ulrike Becker, Louisa van den Boom, et al.
BMJ Open|February 13, 2021
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocolJulia Fuchs, Janet M Allen, Charlotte K Boughton, et al.
Lancet (London, England)|October 8, 2018
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trialMartin Tauschmann, Hood Thabit, Lia Bally, et al.
Wiener Klinische Wochenschrift|August 28, 2024
[Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association]Antonia-Therese Kietaibl, Ingrid Schütz-Fuhrmann, Latife Bozkurt, et al.
BMJ Open|March 15, 2020
Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocolCharlotte Boughton, Janet M Allen, Martin Tauschmann, et al.
Journal of Diabetes Science and Technology|April 4, 2017
Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial SubstudyKatharine D Barnard, Timothy Wysocki, Vanessa Ully, et al.
Diabetes, Obesity & Metabolism|January 26, 2026
International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoringJohn S Pemberton, Robert C Andrews, Katharine Barnard-Kelly, et al.
BMJ Open|July 16, 2017
Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocolLia Bally, Hood Thabit, Martin Tauschmann, et al.
Pageof 7